ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
S. Guillet(Assistance Publique – Hôpitaux de Paris), Frédéric Geissmann(Memorial Sloan Kettering Cancer Center), Rohan Bareja(Cornell University), Tomi Lazarov(Memorial Sloan Kettering Cancer Center), Nico Lachmann(Medizinische Hochschule Hannover), Morgan Huse(Memorial Sloan Kettering Cancer Center), Chihiro Nishi(Osaka International University), Nicholas D. Socci, Jean‐Laurent Casanova(Howard Hughes Medical Institute), W. Todd Miller(Memorial Sloan Kettering Cancer Center), Rosa Fregel(Universidad de La Laguna), Sabrina D. Dyall(University of Mauritius), Ting Zhou(Kettering University), Olivier Elemento(Cornell University), Hairu Yang(Memorial Sloan Kettering Cancer Center), Agnès Viale(Genomics (United Kingdom)), María Tello‐Lafoz(Memorial Sloan Kettering Cancer Center), David Isenberg(Regenerative Medicine Institute), Frédéric Rieux‐Laucat(Inserm), Laurent Abel(Inserm), Shigekazu Nagata(The University of Osaka), Barbara P. Craddock(Memorial Sloan Kettering Cancer Center), Bertrand Boisson(Inserm), Natasha Jordan(King's College London), David D’Cruz(St Thomas' Hospital)
Cited by 1
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
|Science|2000|1.8k
The Conformational Plasticity of Protein Kinases
|Cell|2002|1.8k